Kiran Mazumdar-Shaw Quotes
-
It is always nice to reflect on how one started.
-
My legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.
-
Being in a field like healthcare, for me, as someone who is basically on a mission to make a global impact in terms of affordable access to healthcare, I am very, very concerned about the fact that there are a large number of people in this world who need to have some access to basic rights, whether it is in education or healthcare.
-
In India, I personally believe yes, there is a clear fear of unknown; there's a lot of risk aversions in science and technology. They want predictability in everything they do, and it starts from people. It starts from investors. It starts from the regulators. You see that mindset across the society.
-
Design, art, and science are all a melange.
-
My passion for innovation and my interest in the 'business of science' has seen Biocon commercialize many innovative platforms and products.
-
I do serve on various boards and I'm very honest and frank, obviously. I am a very forthright person and I do, sort of, share my candid views on anything.
-
In Vedic times, we had the great quest for the unknown. We did wonderful things; we celebrate our past vigyaan and our wonderful heritage of science and technology of the Vedic times.
-
I have a great team who has helped me build Biocon, I was very fortunate to be able to share my vision with a group of people who really were as excited about challenges as I was.
-
Innovation and commerce are as powerful tools for creating social progress as they are for driving technological advancement.
-
I belong to the breed of first-generation entrepreneurs who have basically created our enterprises with very frugal resources.
-
My father was a brew master. He was the one who I was very close to, he influenced me in many many ways including my pursuing a career as a brew master.
-
Biocon is on a journey of making impact on global healthcare. I have to make sure that I have one in five persons who needs insulin therapy to use a Biocon product - that is my dream.
-
I am very passionate about India's place in bio-pharmaceuticals, and that is what I really want to drive and create leadership for in India because I really think it is possible.
-
India is a fertile ground for entrepreneurs, given its large pool of world-class talent and resources. India's ability to generate wealth and create social good will come if we let entrepreneurs flourish by encouraging and enabling innovation.
-
I don't know whether I can call myself a visionary.
-
When I started Biocon in 1978, the obstacles I needed to navigate were manifold - ranging from infrastructural hurdles to issues related to my credibility as a business woman. With no access to venture capital, money was scarce and high-cost, debt-based capital was all I had.
-
It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.
-
I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already doing in the developing world because we didn't have access to these drugs. Biocon enjoys a large reputation of giving them high-quality cancer drug.
-
I hate the title of being called 'the richest woman in India,' but it's the recognition that this was the value that I had created as a woman entrepreneur, and that makes me very, very proud.
-
I want to be remembered as someone who put India on the scientific map of the world in terms of large innovation. I want to be remembered for making a difference to global healthcare. And I want to be remembered as someone who did make a difference to social economic development in India.
-
The brewing industry is a very, very male dominated industry. It's a male bastion.
-
One of my objectives when I started Biocon was to make sure that I create a company for women scientists to pursue a vocation.
-
Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very, very strong balance sheet with huge value drivers at the end of it.